ANTX

NASD AN2 Therapeutics, Inc.

Nov 4, 2026 · 9:59 PM ET EOD Market Closed

$4.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.25, $0.06 below the day’s high of $4.31

YTD change: +272.81%
vs 20-day SMA: +6.48%
vs 200-day SMA: +3.64%

Price ranges

Previous day

$4.10 $4.55

open $4.38 close $4.18

-$0.20 (-4.57%)

Today

$4.10 $4.31

open $4.22 now $4.25

+$0.03 (+0.71%)

Past week

$3.85 $4.90

from $3.86 now $4.25

+$0.39 (+10.10%)

Past month

$3.21 $5.07

from $5.07 now $4.25

-$0.82 (-16.17%)

This year

$1.00 $7.19

from $1.14 now $4.25

+$3.11 (+272.81%)

Price & Performance

-0.60 (-12.37%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 82.0% away from all-time highs of $23.58
ANTX is up 273% since the beginning of the year
ANTX is up 273% over the past 12 months
ANTX is down 16% over the past 1 month
9% of all ANTX investors are betting against ANTX

ANTX reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +272.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.18

Earnings momentum +10.0% Quarterly EPS growth

Quarterly change +10.0%

Valuation

P/E ratio N/A

Enterprise value $108.7M

Beta -2.31

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$78.4M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $188.0M

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$478.48	+3.73%
MRNA	Moderna, Inc.	$258.38	+13.11%
RVMD	Revolution Medicines, Inc.	$199.70	+2.82%
ROIV	Roivant Sciences Ltd.	$38.23	+6.08%
BNTX	BioNTech SE Sponsored ADR	$90.70	+4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.